| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |